Treatment of cancer with human chorionic gonadotropin

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 38/24 (2006.01) A61K 38/09 (2006.01)

Patent

CA 2196748

Methods useful for treating cancers are disclosed. The methods involve administering human chorionic gonadotropin (hCG) or human luteinizing hormone (hLH) to patients having cancers. Articles of manufacture that are useful for carrying out the described methods are also described. The claimed methods are effective against breast, prostate, ovary, and stomach carcinomas, as well as neuroblastomas, and Kaposi's sarcoma, among others.

L'invention se rapporte à des procédé utilisés dans le traitement des cancers. Ces procédés consistent à administrer de la gonadotrophine chorionique humaine (hCG) ou l'hormone lutéinisante humaine (hLH) à des patients atteints de cancers. L'invention se rapporte également à des produits manufacturés qui sont utiles pour réaliser ces procédés. Les procédés revendiqués sont efficaces contre les cancers du sein, de la prostate, des ovaires et de l'estomac, et également contre les neuroblastomes et la maladie de Kaposi, entre autres.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Treatment of cancer with human chorionic gonadotropin does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Treatment of cancer with human chorionic gonadotropin, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of cancer with human chorionic gonadotropin will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1636714

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.